Fakultas Kedokteran Universitas Andalas

DAFTAR PUSTAKA

1. WHO. Media Centre: Cardiovascular disease. World Health Organization.

2017; 1-5.

2. Kementrian Kesehatan. Situasi Kesehatan Jantung. Kemenkes RI.

2014;109(1):5–10.

3. WHO. 2017 ICD-10-CM Diagnosis Code J84. 2017;21–3.

4. Robbins SL, Cotran RS, Kumar V. Buku Ajar Patologi Robbins. 7th

edition. vol 2. Jakarta: EGC; 2013. 369-378.

5. Jaffe AS. Third Universal Definition of Myocardial Infarction. Clinical

Biochemistry. 2013;46(1–2):1–4.

6. Alwi I. Infark Miokard Akut dengan elevasi ST. Dalam: Sudoyo AW,

Setiyohadi B, dkk. Buku Ajar Ilmu Penyakit Dalam Jilid II. Edisi VI.

Jakarta: Interna Publishing; 2014. 1457-1472.

7. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos

JA, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation

Myocardial Infarction: A Report of the American College of Cardiology

Foundation/American Heart Association Task Force on Practice

Guidelines. Journal of the American Heart Association. 2013;127(4):362–

425.

8. Srimahachota S, Boonyaratavej S, Kanjanavanit R, Sritara P,

Krittayaphong R, Kunjara-Na-Ayudhya R, et al. Thai Registry in Acute

Coronary Syndrome (TRACS) - An Extension of Thai Acute Coronary

Syndrome Registry (TACS) group: Lower in-hospital but still High

Mortality at One-year. Journal of the Medical Association of Thailand.

2012;95(4):508–18.

9. Gayatri NI, Firmansyah S, S SH, Rudiktyo E. Prediktor Mortalitas Dalam-

Rumah-Sakit Pasien Infark Miokard ST Elevation ( STEMI ) Akut di

RSUD dr . Dradjat Prawiranegara Serang , Indonesia. Jurnal Cermin Dunia

Kedokteran. 2014;43(3):171–4.

10. Prara MR. Kejadian Kardiovaskular Mayor Selama Rawatan pada Infark

Miokard Akut dengan Elevas Segmen ST (IMA-EST) di RSUP Dr. M.

Djamil Padang (Skripsi). Padang: Universitas Andalas; 2017.

Fakultas Kedokteran Universitas Andalas

11. Banerjee AK, Kumar S. Guidelines for Management of Acute Myocardial

Infarction. The Journal of the Association of Physicians of India.

2011;59(12):37–42.

12. Kip KE, Hollabaugh K, Marroquin OC, Williams DO. The Problem With

Composite End Points in Cardiovascular Studies. The Story of Major

Adverse Cardiac Events and Percutaneous Coronary Intervention. Journal

of the American College of Cardiology. 2008;51(7):701–7.

13. Antman EM. ST-Segment Elevation Myiocardial Infarction: Pathology,

Pathophysiology, and Clinical Features. In: In Bonow RO, Mann DL, Zipes

DP, Libby P BE, editor. Heart Disease : A textbook of Cardiovascular

Medicine. 9th ed. Philadelphia: Elsevier; 2012. 1087–1099.

14. Granger CB. Predictors of Hospital Mortality in the Global Registry of

Acute Coronary Events. Archives of Internal Medicine.

2003;163(19):2345.

15. Arso IA, Setianto BY, Taufiq N, Hartopo AB. In-hospital Major

Cardiovascular Events between STEMI Receiving Thrombolysis Therapy

and Primary PCI. Acta Medica Indonesiana. 2014;46(2):124–130.

16. Keeley EC, Velez C a, O’Neill WW, Safian RD. Long-term Clinical

Outcome and Predictors of Major Adverse Cardiac Events after

Percutaneous Interventions on Saphenous Vein Grafts. Journal of the

American College of Cardiology. 2001;38(3):659–665.

17. Lee JH, Park HS, Chae SC, Cho Y, Yang DH, Jeong MH, et al. Predictors

of Six-Month Major Adverse Cardiac Events in 30-Day Survivors After

Acute Myocardial Infarction (from the Korea Acute Myocardial Infarction

Registry). American Journal of Cardiology. 2009;104(2):182–189.

18. Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML,

Williams DO, et al. Thrombolytic Therapy vs Primary Percutaneous

Coronary Intervention for Myocardial Infarction in Patients Presenting to

Hospitals Without On-site Cardiac Surgery. The Journalof the American

Medical Association. 2002;287(15):1943–1951.

19. Leonard SL. Pathophysiology of Heart Disease. 6th ed. Boston: Wolters

Kluwer; 2016. 115-189.

20. Rilantono L. 5 Rahasia Penyakit Kardiovaskular PKV. Jakarta: Fakultas

Kedokteran Universitas Indonesia; 2012. 121.

Fakultas Kedokteran Universitas Andalas

21. Price S. Patofisiologi Konsep Klinis Proses-proses Penyakit. 6th ed.

Jakarta: EGC; 2005. 579-585.

22. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ,

Dennison Himmelfarb C, et al. 2017 ACC /AHA /AAPA /ABC /ACPM

/AGS /APhA /ASH /ASPC /NMA /PCNA Guideline for the Prevention,

Detection, Evaluation, and Management of High Blood Pressure in Adults.

Journal of the American College of Cardiology. 2017. 22

23. Musunuru K. Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary

Intervention. Lipids. 2010;45(10):907–914.

24. Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, et

al. The Impact of Obesity on Cardiovascular Disease Risk Factors and

Subclinical Vascular Disease: the Multi-Ethnic Study of Atherosclerosis.

Archives of Internal Medicine. 2008;168(9):928–935.

25. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Pedoman

Tatalaksana Sindrom Koroner Akut. Edisi ketiga. Jakarta; Centra

Communications. 2015;43-59.

26. Muchid A, Umar F, Chusun. Pharmaceutical Care Untuk Pasien Penyakit

Jantung Koroner Akut. Departemen Kesehatan. 2006;1–3.

27. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H,

et al. 2017 ESC Guidelines for the Management of Acute Myocardial

Infarction in Patients Presenting with ST-segment Elevation. European

Heart Journal. 2017;1–66.

28. Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al.

ESC Guidelines for the Management of Acute Myocardial Infarction in

Patients Presenting with ST-segment Elevation. European Heart Journal.

2012;33(20):2569–619.

29. Hicks KA, Hung HMJ, Mahaffey KW, Mehran R, Nissen SE, Stockbridge

NL, et al. Standardized Definitions for Cardiovascular and Stroke End

Point Events in Clinical Trials. Draft Definition for CDISC .2014;1–33.

30. Cannon CP, Brindis RG, Chaitman BR, Cohen DJ, Cross JT, Drozda JP, et

al. 2013 ACCF/AHA Key Data Elements and Definitions for Measuring

the Clinical Management and Outcomes of Patients With Acute Coronary

Syndromes and Coronary Artery Disease: A Report of the American

College of Cardiology Foundation/American Heart Association . Journal of

the American Heart Association. 2013;127(9):1052–1089.

Fakultas Kedokteran Universitas Andalas

31. Eliana F. Penatalaksanaan DM Sesuai Konsensus Perkeni 2015. Satelit

Simposium 6.1 DM Update dan Hb1C. 2015;1–7.

32. Suparmin S. Beda Kadar Glukosa Darah pada Pria Perokok dan Bukan

Perokok Tembakau Usia 20-60 Tahun di Salemba Tahun 2009-2010.

Jakarta: Universitas Indonesia. 2010. 24.

33. Mardjono M, Sidharta P. Neurologi Klinis Dasar. Jakarta: Penerbit Dian

Rakyat. 2009. 269.

34. Woodroff PG, Schane RA. Chronic Obstructive Pulmonary

Disease:Management of Chronic Disease. Dalam: Albert RK, Allen MS.

Clinical Respiratory Medicine. 3rd Ed. Philadelphia: Elsevier. 2008. 523.

35. Suwitra K. Penyakit Ginjal Kronik. Dalam: Sudoyo AW, Setiyohadi B,

dkk. Buku Ajar Ilmu Penyakit Dalam Jilid II. Edisi VI. Jakarta: Interna

Publishing; 2014. 2159-2165.

36. Information Services Division (ISD). Scottish Heart Disease Statistics -

Year ending 31 March 2016. National Services Scotland. 2017. 9

37. Danny SS, Roebiono PS, Soesanto AM, Danny SS, Roebiono PS, Soesanto

AM. Factors Influencing Major Cardiovascular Event Post Acute

Myocardial Infarction in Woman. Jurnal Kardiologi Indonesia.

2009;30(1):3–12.

38. Stenestrand U, Lindback J, Wallentin L, Registry R-H. Long-term outcome

of primary percutaneous coronary intervention vs prehospital and in-

hospital thrombolysis for patients with ST-elevation myocardial infarction.

The Journalof the American Medical Association. 2006;296(14): 1749-

1756.

39, Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van

Domburg RT, et al. Angiographic Stent Thrombosis After Routine Use of

Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction. The

Importance of Thrombus Burden. Journal of the American College of

Cardiology. 2007;50(7):573–583.

40. Tatlisu MA, Kaya A, Keskin M, Uzman O, Borklu EB, Cinier G, et al. The

association of the coronary thrombus burden with all-cause mortality and

major cardiac events in ST-segment elevation myocardial infarction

patients treated with tirofiban. Coronary Artery Disease. 2016;27(7):543–

550.

Fakultas Kedokteran Universitas Andalas

41. Primulti D-, Hassan A, Elguindy A, Antoniucci D. Culprit lesion-only

versus complete revascularization in patients with STEMI : Lessons learned

from PRAMI. A Qatar Foundation Academic Journal. 2015: 2-5.

42. Dalal J, Sahoo PK, Singh RK, Dhall A, Kapoor R, Krishnamurthy A, et al.

Role of thrombolysis in reperfusion therapy for management of AMI:

Indian scenario. Indian Heart Journal.2013;65(5):566-585.